¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Toxic effect of contact with venomous animals"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • contact inhibition
    Á¢Ã˾ïÁ¦
  • contact irradiation
    Á¢ÃËÁ¶»ç¹ý
  • contact lens
    ÄÜÅÃÆ®·»Áî, Á¢ÃË·»Áî
  • contact media
    Á¢Ã˸Ű³¹°
  • contact radiography
    ±ÙÁ¢¹æ»ç¼±ÃÔ¿µ(¼ú)
  • contact scan
    Á¢Ã˽ºÄµ
  • contact scanner
    Á¢Ã˽ºÄ³³Ê
  • contact stomatitis
    Á¢ÃËÀԾȿ°, Á¢Ã˱¸³»¿°
  • contact ulcer
    Á¢Ã˱˾ç
  • contact urticaria
    Á¢Ã˵ε巯±â
  • extended-wear contact lens
    ¿¬¼ÓÂø¿ëÄÜÅÃÆ®·»Áî, ¿¬¼ÓÂø¿ëÁ¢ÃË·»Áî
  • heel contact
    µÚÃàµó±â
  • hard contact lens
    ÇϵåÄÜÅÃÆ®·»Áî, °æ¼ºÄÜÅÃÆ®·»Áî
  • hydrophilic contact lens
    Ä£¼öÄÜÅÃÆ®·»Áî
  • irritant contact dermatitis
    ÀÚ±ØÁ¢ÃËÇǺο°
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • inhibitory effect
    ¾ïÁ¦È¿°ú
  • palliative effect
    ¿ÏÈ­È¿°ú, °æ°¨È¿°ú
  • prolonged effect
    Áö¼ÓÈ¿°ú
  • radiation effect
    ¹æ»ç¼±È¿°ú
  • reversing effect
    ¿ªÀüÈ¿°ú
  • shielding effect
    Â÷ÆóÈ¿°ú, °¡¸²È¿°ú
  • stochastic effect
    È®·ü·ÐÀûÈ¿°ú
  • synergistic effect
    »ó½ÂÈ¿°ú
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • contact scan
    Á¢Ã˽ºÄµ
  • contact scanner
    Á¢Ã˽ºÄ³³Ê
  • contact scanning
    Á¢Ã˽ºÄ³´×
  • contact stomatitis
    Á¢ÃËÀԾȿ°, Á¢Ã˱¸³»¿°
  • contact urticaria
    Á¢Ã˵ε巯±â
  • contact compound scan
    Á¢Ã˺¹ÇÕ½ºÄµ
  • contact gunshot wound
    Á¢»çÃÑ»ó
  • contact scrotal thermography
    À½³¶Á¢Ã˿µµÃøÁ¤¼ú
  • heel contact
    µÚÃàµó±â
  • immediate contact
    Áï½ÃÁ¢ÃË
  • indirect contact
    °£Á¢Á¢ÃË
  • intercellular contact
    ¼¼Æ÷»çÀÌÁ¢ÃËÃþ
  • primary contact
    ÀÏÂ÷Á¢ÃË
  • proximal contact
    ÀÎÁ¢
  • secondary contact
    ÀÌÂ÷Á¢ÃË
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Bernouilli effect
    º£¸£´©ÀÌ È¿°ú
  • Bohr effect
    º¸¾Æ È¿°ú(üùÍý)
  • CPE=£¾cytopathogenic effect
    ¼¼Æ÷º´º¯È¿°ú.
  • CPE=£¾cytopathogenic effect
    ¼¼Æ÷º´º¯È¿°ú.
  • Cytopath(ogen)ic effect, CPE
    ¼¼Æ÷º´º¯È¿°ú
  • Donnan effect
    µ·³­È¿°ú
  • Doppler effect
    µµÇ÷¯ È¿°ú
  • Fahraeus-Lindqvist effect
    ÆÄ·¹¿ì½º-¸°Äûºñ½ºÆ® È¿°ú(üùÍý)
  • Fenn effect
    Ææ È¿°ú(üùÍý)
  • Gibbs effect
    ±é½º È¿°ú
  • HIV effect
    HIV È¿°ú<ÀÛ¿ë>
  • Haldane effect
    ÇÒµ§È¿°ú
  • Purkinje effect
    Ǫ¸£Å°´Ï¿¡È¿°ú
  • RF antennae effect
    °íÁÖÆÄ ¾ÈÅ׳ª È¿°ú
  • Stiles-Crawford effect
    ½ºÅ¸ÀϽº-Å©·ÎÆ÷µåÈ¿°ú
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • contact blepharitis
    Á¢ÃË´«²¨Ç®¿°Áõ, Á¢Ã˾Ȱ˿°
  • contact carrier
    Á¢Ã˺¸±ÕÀÚ(ÊÙËÓË»Ëö).
  • contact cheilitis
    Á¢ÃË(ïÈõº) ÀÔ¼ú¿°
  • contact comfort
    Á¢ÃËÀ§¾È(ïÈõºêÐäÌ)
  • contact compound scan
    Á¢ÃË º¹ÇÕ ½ºÄµ
  • contact compound scan
    Á¢ÃË º¹ÇÕ (ïÈõº ÜÜùê) ½ºÄµ
  • contact compound scanner
    Á¢ÃË º¹ÇÕ (ïÈõº ÜÜùê) ½ºÄ³³Ê
  • contact dermatitis
    Á¢ÃËÇǺο°(ù«Ý±æú)
  • contact dermatitis
    Á¢Ã˼º ÇǺο°
  • contact dermatoconjunctivitis
    Á¢ÃËÇǺΰḷ¿°
  • contact eczema
    Á¢Ã˽ÀÁø
  • contact hypersensitivity
    Á¢Ã˼º °ú¹Î¹ÝÀÀ
  • contact immunotherapy
    Á¢ÃË ¸é¿ª Ä¡·á
  • contact infection
    Á¢Ã˰¨¿°
  • contact inhibition
    Á¢ÃËÀúÁö
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Compton effect
    ÄÞÅæ È¿°ú(üùÍý)
  • Cotton effect
    ÄÚÅæ È¿°ú(üùÍý)
  • Coulomb effect
    "Äí·Õ È¿°ú(üùÍý),(ÔÒ) ion-ion interaction"
  • Crabtree effect
    Å©·¡ºêÆ®¸® È¿°ú(üùÍý)
  • dispersion effect
    "ºÐ»ê È¿°ú(ÝÂߤüùÍý), (ÔÒ) dispersion forces"
  • Dorn effect
    "µ· È¿°ú(üùÍý), (ÔÒ) sedimentation potential"
  • drag effect
    ²ø¸² È¿°ú(üùÍý) (ÔÒ) solvent drag
  • dual-effect mutant
    ÀÌÁßÈ¿°ú º¯ÀÌü(ì£ñìüùÍýܨì¶ô÷)
  • electrochromic effect
    Àü±âº¯»ö È¿°ú(ï³Ñ¨Ü¨ßäüùÍý)
  • electrophoretic effect
    Àü±â¿µµ¿ È¿°ú(ï³Ñ¨ç¶ÔÑüùÍý)
  • electroviscous effect
    Àü±âÁ¡¼º È¿°ú(ï³Ñ¨ïÄàõüùÍý)
  • enhancement effect
    Áõ°­ È¿°ú (ñòË­üùÍý)
  • extrinsic Cotton effect
    ¿ÜÀμº(èâì×àõ) ÄÚÆ° È¿°ú(üùÍý)
  • Faraday effect
    ÆÐ·¯µ¥ÀÌ È¿°ú(üùÍý)
  • field effect
    ÀåÈ¿°ú(íÞüùÍý)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Doppler effect
    µµÇ÷¯È¿°ú
  • effect
    È¿°ú, ÀÛ¿ë
  • entry slice effect
    À¯ÀԴܸéÈ¿°ú
  • fast scan effect
    °í¼Ó½ºÄµÈ¿°ú
  • Gibbs effect
    ±é½º È¿°ú
  • gradient echo effect
    °æ»ç¿¡ÄÚÈ¿°ú
  • gradient induced phase shift effect
    °æ»çÀ¯µµ À§»óº¯À§È¿°ú
  • halo effect
    ´Þ¹«¸®È¿°ú
  • immediate effect
    Áﰢȿ°ú, Áï½ÃÈ¿°ú
  • in-flow effect
    À¯ÀÔ È¿°ú
  • iron effect
    öȿ°ú
  • mach effect
    ¸¶ÇÏÇö»ó
  • magnetization transfer effect
    ÀÚÈ­Àü´ÞÈ¿°ú
  • main effect
    ÁÖÀÛ¿ë
  • mass effect
    Á¾±«È¿°ú
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ImD50 immunizing dose sufficient to protect 50% of the animals in a test group
RSPCA Royal Society for the Prevention of Cruelty to Animals
SPCA serum prothrombin conversion accelerator; Society for Prevention of Cruelty to Animals
WARDS Welfare of Animals Used for Research in Drugs and Therapy
ACD   1) Absolute Cardiac Dullness; Àý´ë½ÉµÐŹÀ½
  2) Anemia of Chronic Disease
&nbs...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CS Contact sensitivity
ICD Irritant contact dermatitis
NCT Non Contact Tonometer
SCL Soft contact lens
% C contact
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • assisted mediotrusive contact
    ³»Ãø¹æ À¯µµ Á¢ÃË
  • balancing occlusal contact
    ±ÕÇü ±³ÇÕ Á¢ÃË
    ºÎÀûÀýÇÑ ¿ë¾î. nonworking occlusal contactÀ» º¸½Ã¿À.
  • centric occlusal contact
    Á᫐ ±³ÇÕ Á¢ÃË
  • contact angle
    Á¢ÃË °¢
    °íü Ç¥¸é»ó¿¡ ¿ë¾×ÀÇ ¹æ¿ïÀ» ¶³¾î¶ß¸± °æ¿ì, °íü ¸é°ú ¾×ÀÚÀ¯Ç¥¸éÀÌ ÀÌ·ç´Â °¢.
  • contact area
    Á¢Ã˺Î
  • contact cheilitis
    Á¢Ã˼º ±¸¼ø¿°
  • contact dermatitis
    Á¢Ã˼º ÇǺο°, Á¢ÃË ÇǺο°
    ¿ÜºÎÀÇ ¹°Áú¿¡ Á¢ÃËÇÔÀ¸·Î½á ÀϾ´Â ÇǺÎÀÇ ¿°ÁõÀÌ´Ù. À̸¥¹Ù ÇǺΰ¡ Çã´Â °ÍÀ¸·Î °¡·Á¿òÀÌ Æ¯Â¡ÀÌ´Ù. ±Þ¼º ½ÀÁø°ú °°Àº Áõ¼¼¸¦ ¶ìÁö¸¸, ¿ÜºÎ¿¡¼­ ÀÛ¿ëÇϴ ƯÁ¤ÀÇ ¹°Áú¿¡ ´ëÇÑ ¹ÝÀÀÀ¸·Î¼­ ÀϾ´Â Á¡ÀÌ ½ÀÁø°ú ´Ù¸£´Ù. ¹ßº´Çϱ⠽¬¿î ¹°Áú·Î´Â ¿Ì³ª¹«, °Ë¾ç ¿Ì³ª¹«, ¹«È­°ú³ª¹«, ÀºÇ೪¹« µîÀ» ºñ·ÔÇÏ¿©, µµ·á, ÇÕ¼º ¼öÁö Á¦Ç°, ÇÇÇõ Á¦Ç°, °í¹« Á¦Ç°, Å©·Ò µµ±Ý, ¾àǰ, È­Àåǰ·ù ¹× ÇÕ¼º ¼¶À¯·Î ¸¸µç ¼Ó¿Ê µîÀ» µé ¼ö ÀÖ´Ù.
  • contact infection
    Á¢ÃË °¨¿°
    º¸±ÕÀÚ, ¶Ç´Â º´¿øÃ¼°¡ ºÎÂøÇÑ ÀǺ¹, ¹°Ç° µî¿¡ Á÷Á¢ ´ê¾Æ ÇǺγª Á¡¸·À¸·Î °¨¿°µÇ´Â Àü¿°º´ÀÇ ÀüÆÄ ¾ç½Ä. ÀÓÁú, ¸Åµ¶, Æ®¶óÄÚ¸¶ µîÀÌ ´ëÇ¥Àû ÁúȯÀÌ´Ù. ȯÀÚ³ª º¸±ÕÀÚÀÇ º´¿øÃ¼°¡ ±âħ, Àçä±â, ´ëÈ­ µîÀ» ÅëÇÏ¿© »ç¶÷ÀÇ ÄÚ³ª ¸ñ±¸¸ÛÀÇ Á¡¸·¿¡ ºñ»ê, ºÎÂøÇÏ¿© °¨¿°À» ÀÏÀ¸Å°´Â ºñ¸» °¨¿°µµ Á¢ÃË °¨¿°¿¡ Æ÷ÇÔ½ÃŲ´Ù. ÀÎÇ÷翣ÀÚ, Æó°áÇÙ µîÀÌ ÀÌ¿¡ ¼ÓÇÑ´Ù.
  • contact irradiation
    ±ÙÁ¢ Á¶»ç, ±ÙÁ¢ Á¶»ç¹ý
  • contact media
    Á¢ÃËÁ¦
  • contact mode
    Á¢ÃËÇü
  • contact potential difference
    Á¢ÃË ÀüÀ§Â÷
  • contact scan
    Á¢ÃË ½ºÄµ
  • contact surface
    Á¢Ã˸é
    °£È¤ »óÇÏ Ä¡¾Æ°£ ±³ÇÕ¸é Á¢ÃËÀ» °¡¸®Å°´Â °æ¿ìµµ ÀÖ´Ù.
  • contact time
    Á¢ÃË ½Ã°£
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
toxic Pertaining to, due to or of the nature of a poison or toxin, manifesting the symptoms of severe infection.
(18 Nov 1997)
toxic amaurosis Blindness due to optic neuritis caused by methyl alcohol, lead, arsenic, quinine, or other poisons.
(05 Mar 2000)
toxic amblyopia Blindness due to optic neuritis caused by methyl alcohol, lead, arsenic, quinine, or other poisons.
(05 Mar 2000)
toxic anaemia Any anaemia resulting from the destructive effects of a chemical, metabolic poison, bacterial toxin, venom, and similar materials.
(05 Mar 2000)
toxic cataract A cataract caused by drugs or chemicals.
(05 Mar 2000)
toxic cirrhosis Cirrhosis of the liver resulting from chronic poisoning, as by lead or carbon tetrachloride.
(05 Mar 2000)
toxic cyanosis Cyanosis due to methemoglobin formation resulting from the action of certain drugs, e.g., nitrites.
(05 Mar 2000)
toxic delirium Delirium caused by the action of a poison.
(05 Mar 2000)
toxic epidermal necrolysis A syndrome in which a large portion of the skin becomes intensely erythematous with epidermal necrosis, and peels off in the manner of a second-degree burn, often simultaneous with the formation of flaccid bullae, resulting from drug sensitivity or of unknown cause; the level of separation is subepidermal, unlike staphylococcal scalded skin syndrome in which there is subcorneal change.
Synonym: Lyell's syndrome.
(05 Mar 2000)
toxic equivalent The amount of toxin or other poison per kilogram of body weight necessary to kill an animal.
(05 Mar 2000)
toxic goiter A goiter that forms an excessive secretion, causing signs and symptoms of hyperthyroidism.
(05 Mar 2000)
toxic haemoglobinuria Haemoglobinuria occurring after the ingestion of various poisons, in certain blood diseases, and in certain infections.
(05 Mar 2000)
toxic hydrocephalus Thrombotic hydrocephalus associated with some general infection or toxic state.
(05 Mar 2000)
toxic megacolon <gastroenterology, surgery> An acute nonobstructive dilation of the colon, seen in advanced ulcerative colitis and Crohn's disease.
(12 Jan 1998)
toxic multinodular goiter Condition in which the thyroid gland contains multiple lumps (nodules) that are overactive, produce excess thyroid hormones and thereby cause hyperthyroidism. This condition is also known as parry's disease or plummer's disease.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • contact ingibition
    Á¢ÃËÀúÁö(¹è¾ç¼¼Æ÷°¡ ¼­·Î Á¢ÃËÇÏ¿© ±â´ÉÀÌ Á¤ÁöµÇ±â)
  • contact lens
    ÄÜÅÃÆ® ·»Áî
  • contact maker
    (Àü·ùÀÇ)Á¢Ã˱â
  • contact man
    (°Å·¡µîÀÇ)Áß°³ÀÚ;Á¤º¸Á¦°øÀÚ;(°ü°ø¼­µî¿¡ ´ëÇÑ)¼·¿ÜÀÚ;(½ºÆÄÀ̵îÀÇ)¿¬¶ô¿ø
  • contact metamorphism
    Á¢Ã˺¯¼ºÀÛ¿ë
  • contact mine
    Ã˹߼ö·Ú(±â·Ú,Áö·Ú)
  • contact paper
    ¹ÐÂø(ÀÎÈ­)Áö
  • contact potential
    Á¢ÃË ÀüÀ§Â÷
  • contact print
    ¹ÐÂø ÀÎÈ­
  • contact process
    (Ȳ»êÁ¦Á¶ÀÇ)Á¢Ã˹ý 0
  • contact visit
    Á¢Ã˹湮(¼ö°¨ÀÚ¿Í ¹æ¹®ÀÚÀÇ ¾Ç¼ö.Æ÷¿ËµîÀÌ Çã¿ëµÊ)
  • eye contact
    ½Ã¼±ÀÌ ¸¶ÁÖħ
  • effect
    °á°ú,¿µÇâ,È¿°ú,½Ç½Ã,ÃÊ·¡ÇÏ´Ù
  • side effect
    ºÎÀÛ¿ë
  • Compton effect
    ÄÞÇÁÅÏ È¿°ú(±¤ÀÚ¿Í ÀüÀÚÀÇ Åº¼º »ê¶õ)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á